These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2999930)

  • 1. Guinea pig protection test as indicator of potency of oil emulsion foot-and-mouth disease vaccines.
    Black L; Pullen L; Boge A
    Res Vet Sci; 1985 Sep; 39(2):207-11. PubMed ID: 2999930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiments on an early protection against foot-and-mouth disease virus.
    Liebermann HT; Thalmann G; Bartels T; Nöckler A
    Acta Virol; 1993; 37(2-3):181-3. PubMed ID: 8105663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Testing the effectiveness of foot-and-mouth disease vaccines: the relationship between test infection results and corresponding neutralization titers of vaccinated cattle].
    Bengelsdorff HJ
    Berl Munch Tierarztl Wochenschr; 1989 Jun; 102(6):193-8. PubMed ID: 2548473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of a bivalent anti-foot-and-mouth disease vaccine with oil adjuvant to a vaccine with DEAE-dextran adjuvant in swine].
    Kihm U
    Dev Biol Stand; 1976; 35():149-53. PubMed ID: 198281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Riems foot-and-mouth disease oil emulsion vaccines for swine. 2. Use of foot-and-mouth 2-component oil emulsion vaccines in practice].
    Nöckler A; Thalmann G; Haack P; Nehmzow P; Poewe R; Pietzsch E; Seils G
    Arch Exp Veterinarmed; 1990; 44(2):183-8. PubMed ID: 2167045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Riems foot-and-mouth disease oil emulsion vaccines for swine. 1. Development and testing of highly effective and well-tolerated foot-and-mouth disease vaccine for swine using Dessauer oil adjuvants].
    Nöckler A; Thalmann G; Bartels T; Haack P
    Arch Exp Veterinarmed; 1990; 44(2):171-82. PubMed ID: 2167044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluates.
    Bauer K
    Dev Biol Stand; 1976; 35():297-300. PubMed ID: 198299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
    Balamurugan V; Renji R; Venkatesh G; Reddy GR; Nair SP; Ganesh K; Suryanarayana VV
    Arch Virol; 2005 May; 150(5):967-79. PubMed ID: 15662485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
    J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response of pigs to foot-and-mouth disease oil emulsion vaccine: the antibody classes involved.
    Ouldridge EJ; Francis MJ; Black L
    Res Vet Sci; 1982 May; 32(3):327-31. PubMed ID: 6285436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Storage-related potency changes in monovalent type O1, A5 and C foot-and-mouth disease vaccine preparations.
    Sólyom F; Fazekas A; Czelleng F
    Acta Vet Acad Sci Hung; 1981; 28(3):289-95. PubMed ID: 6266237
    [No Abstract]   [Full Text] [Related]  

  • 15. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
    Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
    Brehm KE; Kumar N; Thulke HH; Haas B
    Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the immune response of foot-and-mouth disease vaccine type Asia-1 in pregnant ewes, lambs and evaluation of type O vaccine by challenge.
    Nair SP; Sen AK
    Acta Virol; 1994 Oct; 38(5):257-61. PubMed ID: 7725999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
    Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
    Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
    Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
    Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.